Search by Drug Name or NDC

    NDC 39822-0615-02 Colistimethate 150 mg/2mL Details

    Colistimethate 150 mg/2mL

    Colistimethate is a INTRAMUSCULAR; INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by XGen Pharmaceuticals DJB, Inc.. The primary component is COLISTIMETHATE SODIUM.

    Product Information

    NDC 39822-0615
    Product ID 39822-0615_eedca302-5a83-6a5c-e053-2a95a90a7144
    Associated GPIs 16100004202132
    GCN Sequence Number 009357
    GCN Sequence Number Description colistin (colistimethate Na) VIAL 150 MG INJECTION
    HIC3 W1N
    HIC3 Description POLYMYXIN ANTIBIOTICS AND DERIVATIVES
    GCN 41350
    HICL Sequence Number 004051
    HICL Sequence Number Description COLISTIN (AS COLISTIMETHATE SODIUM)
    Brand/Generic Generic
    Proprietary Name Colistimethate
    Proprietary Name Suffix n/a
    Non-Proprietary Name Colistimethate
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
    Route INTRAMUSCULAR; INTRAVENOUS
    Active Ingredient Strength 150
    Active Ingredient Units mg/2mL
    Substance Name COLISTIMETHATE SODIUM
    Labeler Name XGen Pharmaceuticals DJB, Inc.
    Pharmaceutical Class Polymyxin-class Antibacterial [EPC], Polymyxins [CS]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA064216
    Listing Certified Through 2024-12-31

    Package

    NDC 39822-0615-02 (39822061502)

    NDC Package Code 39822-0615-2
    Billing NDC 39822061502
    Package 12 CARTON in 1 CARTON (39822-0615-2) / 1 VIAL in 1 CARTON (39822-0615-1) / 2 mL in 1 VIAL
    Marketing Start Date 2011-01-01
    NDC Exclude Flag N
    Pricing Information N/A